Please Share::
�� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��
��
-->
�� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��
��
Event: FY15 provisional earnings yet again sharply below
expectations; profit plunged ~62%y-y
BHEL released its FY15 provisional results which were sharply below our
expectations on profitability as well as on order inflow. For FY15, revenues
declined ~23.6% y-y while net profit plunged by ~62.1% y-y, missing our
estimates by a wide margin. Order inflow for FY15 at INR308bn was up 10%
y-y mostly led by two large orders booked late into the year but still below
our estimates of INR350bn. We retain our cautious stance on BHEL due to
continued disappointment in order inflows, slower execution, falling margins
and risk on receivables. We reiterate our Reduce rating, and our target price
of INR123 per share implies ~47% downside.
Key highlights
BHEL’s provisional FY15 gross sales at INR308bn declined ~23.6%y-y.
On implied 4Q numbers, gross sales decreased by ~16.7% y-y.
PBT for FY15 at INR19.06bn declined by -62% y-y. PBT margins (based
on gross sales) compressed to 6.2% in FY14 (declined by ~624bps y-y)
and 8.9% in 4QFY14 (declined by ~860bps y-y).
PAT for FY15 at ~INR13.1bn plunged ~62.1% y-y, while implied 4Q PAT
declined by 57.5% y-y (vs Nomura estimate of INR15.6bn in 4Q).
Order inflow of INR308bn was up 10% y-y thus replacing what the
company executed this year but still below our estimate of INR350bn.
Implied EBITDA margins for 4Q was at 9% and for FY15 at 6.4%, which is
the lowest since 2002 down cycle for the company.
Impact
We expect negative stock reaction to this set of provisional numbers as we
do not see any visibility of a turnaround even over the medium term for the
company. Weak order inflow trend also does not infuse any confidence on
revenue growth or margins picking up anytime soon. Thus we retain our
Reduce call on the stock.
No comments:
Post a Comment